Drug recall · May 13, 2026
busPIRone Hydrochloride Tablets recall
Why: Subpotent drug
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufactured by Unichem Laboratories LTD., Ind, Area, Meerut Road, Ghazibad - 201 003, India Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816, NDC 29300-244-05.
- Lots / codes
Lot: ZBUL25001, Exp 12/31/2027
- Quantity
- 10,875 Bottles
- Company
- Unichem Pharmaceuticals USA Inc., East Brunswick, NJ
- Distribution
- USA Nationwide
- Initiated
- April 13, 2026 · Voluntary: Firm initiated
- Classified
- May 1, 2026
- Reported
- May 13, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Buspirone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.